Literature DB >> 9576804

Application of cystamine and N,N'-Bis(glycyl)cystamine as linkers in polysaccharide-protein conjugation.

O de Weers1, M Beurret, L van Buren, L A Oomen, J T Poolman, P Hoogerhout.   

Abstract

Pneumococcal polysaccharide type 6B, 14, or 23F (35-70 kDa) was activated with cyanogen bromide and modified with cystamine. After reduction of the spacer, the thiol-containing (i.e. cysteamine-modified) polysaccharide obtained was added in a 5-10-fold molar excess to bromoacetylated tetanus toxoid to give thioether-linked polysaccharide-protein conjugates in a yield of 10-20%. This approach failed for preparing a type 19F polysaccharide-protein conjugate, possibly due to intramolecular elimination of cysteamine from the reduced 19F polysaccharide. When N,N'-bis(glycyl)cystamine was introduced as a spacer molecule, the elimination of the reduced spacer was suppressed, thus allowing preparation of a 19F polysaccharide-tetanus toxoid conjugate (15%).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576804     DOI: 10.1021/bc9702011

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  2 in total

1.  Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?

Authors:  A Soininen; G van den Dobbelsteen; L Oomen; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 2.  Why might regional vaccinology networks fail? The case of the Dutch-Nordic Consortium.

Authors:  Jan Hendriks; Stuart Blume
Journal:  Global Health       Date:  2016-07-07       Impact factor: 4.185

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.